Hercules Capital delivered first quarter results that were in line with Wall Street expectations, with management crediting disciplined credit underwriting and record origination activity as key drivers. CEO Scott Bluestein emphasized that the company’s balance sheet and liquidity position remained strong despite a volatile market backdrop. He highlighted a deliberate focus on permanent capital structure and asset diversification, noting, “Our portfolio credit performance remains stable and our investment portfolio continued to generate net investment income in Q1 that comfortably covered our base shareholder distribution by 120%.”
Is now the time to buy HTGC? Find out in our full research report (it’s free for active Edge members).
Hercules Capital (HTGC) Q1 CY2026 Highlights:
- Revenue: $141.5 million vs analyst estimates of $141.5 million (18.4% year-on-year growth, in line)
- Adjusted EPS: $0.48 vs analyst estimates of $0.47 (in line)
- Adjusted EBITDA: $92.34 million (65.2% margin, 13.7% year-on-year growth)
- Operating Margin: 62.3%, down from 64.8% in the same quarter last year
- Market Capitalization: $2.97 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Hercules Capital’s Q1 Earnings Call
- Brian McKenna (Citizens): Asked about the disconnect between Hercules’ strong portfolio fundamentals and market perceptions, as well as drivers behind outperformance. CEO Scott Bluestein highlighted disciplined underwriting and portfolio diversification as key reasons for ongoing stability.
- Ben Graham (Piper Sandler): Sought clarity on deployment trends in 2026, especially sector emphasis. Bluestein explained ongoing focus on diversification and strong origination pipeline, driven by both life sciences and technology, with a disciplined approach to capital deployment.
- Cory Johnson (UBS): Inquired about robust M&A activity in Hercules’ portfolio despite broader market slowdown. Bluestein credited the investment team’s ability to identify attractive targets and noted continued strong M&A pipeline, with some variability in timing and valuations.
- Casey Alexander (Compass Point): Questioned whether high prepayments present an opportunity to shift portfolio strategy. Bluestein said repayments allow for repositioning but confirmed ongoing commitment to high-quality software opportunities alongside further diversification.
- John Hecht (Jefferies): Asked about terms and structuring for new tech-related deals, especially amid AI-driven change. Bluestein emphasized prioritizing tighter structure and covenants over higher yields to manage risk in evolving sectors.
Catalysts in Upcoming Quarters
Looking ahead, the StockStory team will be monitoring (1) the pace and quality of capital redeployment following elevated prepayments, (2) continued credit performance and nonaccrual trends amid sector volatility, and (3) the effectiveness of portfolio diversification as market conditions evolve. Developments in AI disruption and regulatory changes in life sciences will also be key to tracking Hercules’ execution.
Hercules Capital currently trades at $16.05, down from $16.57 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
